HD-OPM Archive
Topics › Aging & longevity

High insulin/IGF-1 tied to cancer, diabetes; Laron syndrome and low-IGF-1 mice live longer

Louis Nervegna · May 13, 2025 · ♥ 23 reactions · 13 comments · original Facebook post
Aging & longevityInsulin resistance & diabetesCancer
AI summary & key facts

Louis praises a video on height, insulin/IGF-1 and longevity and lays out his argument: diet (refined starch/sugar and excess animal protein) is the main driver of IGF-1, and low IGF-1 is linked to lower cancer and diabetes risk. He cites Laron syndrome, with no documented cancer deaths, little diabetes and less heart disease and Alzheimer's, and a long-lived low-IGF-1 mouse. Claims come from the post and videos, not named papers.

This is one of the best videos that I’ve seen on the relationship between insulin/IGF1 and longevity.

The person making the video actually understands the major role that insulin/IGF1 plays in the lifespan of mammals, which is rare for an influencer making these kinds of videos. Most people don’t properly understand this subject at all.

High insulin/IGF1 in humans is associated with increased risk of several major diseases, especially cancer and diabetes.

The biggest driver of insulin/IGF1 is diet. The foods that raise IGF1 the most are refined starch/sugar and excessive high-quality animal protein.

↪ Whey protein is highly insulinogenic; Willett wary of powders and IGF-1 cancer risk

(A typical meal at McDonald’s checks both of those boxes. It is the ideal meal to raise IGF1.)

Spoiler alert: Shorter people live longer and have less risk of cancer. This is very likey due to lower levels of IGF1 from birth.

↪ Taller people tend to live shorter lives, likely via growth hormone, IGF-1 and mTOR

This is true for many other species of mammals as well. For example, if you’ve ever owned dogs, then you know that the smaller breeds live much longer than the larger ones. This is likely due in large part to IGF1.

facebook.com/share/r/18hkP5Xtxz

↪ Loyal's dog longevity drug targets insulin/IGF-1; claims lack publications so far

The oldest lab mouse to have ever lived was genetically engineered from birth to have low IGF1. It lived 5 years, setting a world record— whereas a typical lab mouse only lives about 2.5 years.

He mentions the human disease Laron Syndrome in the video. These people have a genetic mutation that blocks their livers from using insulin to convert growth hormone into IGF1. As a result, they have very low IGF1 from birth.

There has NEVER been a documented case of a person with Laron Syndrome dying from cancer. Not a single one. In the few documented cases where they developed cancer, it progressed very slowly and did not ultimately kill them.

People with Laron syndrome almost never develop diabetes, even when very overweight. Rates of heart disease and Alzheimer’s are also considerably lower than in the general population.

#igf1HD #insulinHD #laronsyndromeHD #longevityHD #dogsHD #cancerHD #diabetesHD #mtorHD #alzheimersHD #cvdHD #heightHD #refinedstarchHD #refinedsugarHD #proteinHD #growthhormoneHD

▶Video · YouTube · Siim LandThe Surprising Science Between Height and LongevityP.S. This is not professional medical advice and should not be taken as such. The creator of this video is not held accountable for your health. Consult your doctor first.youtu.be
← newer: Loyal says its IGF-1-lowering dog drug will be available by older: ALLAY-HF study advertisement for a non-surgical heart failur →